COVID Intel - by Dr.William Makis

COVID Intel - by Dr.William Makis

Share this post

COVID Intel - by Dr.William Makis
COVID Intel - by Dr.William Makis
IVERMECTIN - Articles and Protocols for CANCER, Research studies and access to Ivermectin pills
Copy link
Facebook
Email
Notes
More

IVERMECTIN - Articles and Protocols for CANCER, Research studies and access to Ivermectin pills

Dr. William Makis MD's avatar
Dr. William Makis MD
Jul 02, 2024
∙ Paid
366

Share this post

COVID Intel - by Dr.William Makis
COVID Intel - by Dr.William Makis
IVERMECTIN - Articles and Protocols for CANCER, Research studies and access to Ivermectin pills
Copy link
Facebook
Email
Notes
More
90
63
Share

IVERMECTIN RESOURCES:

Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER.

I have two articles and a Video that go into depth:

June 10, 2024 - NEW PODCAST! "15 minutes with Dr.Makis" - Episode 018: High Dose IVERMECTIN and CANCER

April 6, 2024 - IVERMECTIN and CANCER Part 2 - Treating Turbo Cancer - 7 new studies released in 2024 show Ivermectin works against CANCER - suggested PROTOCOLS for COVID-19 mRNA Vaccine Induced Turbo Cancers

Oct. 2, 2023 - IVERMECTIN and CANCER, it has at least 15 anti-cancer mechanisms of action. Can Ivermectin Treat COVID-19 mRNA Vaccine Induced Turbo Cancers? - 9 Ivermectin papers reviewed

IVERMECTIN and CANCER RESEARCH:

Top 5 COVID-19 mRNA Vaccine Induced Turbo Cancers are: Lymphoma, Glioblastoma, Breast, Colon, Lung Cancer.

IVERMECTIN can help with mRNA Induced Turbo Cancer, or regular cancers.

Here are recent studies on IVERMECTIN use in certain types of cancer:

  • BLADDER CANCER - (2024 F…

Keep reading with a 7-day free trial

Subscribe to COVID Intel - by Dr.William Makis to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Dr. William Makis MD
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More